Valneva SE announced that it will report its first half 2026 consolidated financial results on August 13, 2026. The company will host a live webcast to discuss the results and provide a business update. Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases.
